Dyne Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $51.3M | $387.8M | $148.0M |
| Jun 2022 | $53.0M | $340.0M | $136.0M |
| Sep 2022 | $49.9M | $299.7M | $144.9M |
| Dec 2022 | $54.0M | $306.3M | $172.1M |
| Mar 2023 | $46.7M | $288.6M | $181.1M |
| Jun 2023 | $44.5M | $251.4M | $167.6M |
| Sep 2023 | $53.2M | $205.2M | $130.3M |
| Dec 2023 | $73.8M | $165.1M | $121.6M |
| Mar 2024 | $44.2M | $522.3M | $272.0M |
| Jun 2024 | $50.7M | $825.9M | $608.2M |
| Sep 2024 | $63.3M | $768.8M | $532.2M |
| Dec 2024 | $61.4M | $691.2M | $435.4M |
| Mar 2025 | $52.1M | $721.1M | $472.3M |
| Jun 2025 | $157.5M | $729.0M | $485.0M |
| Sep 2025 | $175.3M | $867.1M | $573.6M |
| Dec 2025 | $214.8M | $1.19B | $893.4M |
| Mar 2026 | $214.9M | $1.08B | $753.1M |
| Jun 2026 | $291.9M | $994.0M | $676.1M |